12
Participants
Start Date
September 1, 2020
Primary Completion Date
November 18, 2022
Study Completion Date
Dupilumab Prefilled Syringe
open-label
Bernstein Clinical Research Center, Cincinnati
Jonathan A. Bernstein, MD
OTHER